In a phase IIa, randomized, open-label study with an active comparator, efinopegdutide was compared with semaglutide over 24 weeks in individuals with elevated liver fat content (LFC)
UnitedHealthcare Weight Loss Medication Coverage UnitedHealthcare, the largest commercial insurer in the United States, significantly expanded its weight loss medication coverage in 2025 and 2026
Your provider will discuss whether to continue, adjust, or discontinue semaglutide based on individual circumstances
Molecular structure and translocation of a multiple antibiotic resistance region of a Psychrobacter psychrophilus permafrost strain
Global economic instability, inflationary pressures, and geopolitical conflicts can disrupt supply chains, reduce consumer spending, and shift regulatory priorities